Patent · US Active

Purification chemistries and formats for Sanger DNA sequencing reactions on a micro-fluidics device

US11905557B2 · kind B2 · utility

0Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2021
Grant dateFeb 20, 2024
Priority date
Expiry dateDec 9, 2041

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01L2300/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

According to various embodiments described herein, a microfluidics-chip based purification device and system for Sanger-sequencing reactions is provided. The device and system allow for the introduction into a sequencing system of a cartridge containing purification technologies specific to the sequencing contaminants or sequencing method where the simplified purification solution of a cartridge allows automation of the sample purification process, reduced consumption of purification reagents, and consistency in sampling by reducing the sampling errors and artifacts. These various embodiments therefore solve the need for a microfluidics-chip-based, Sanger-sequencing reaction purification system for CE devices. The microfluidic chips described can be used as a PCR chip by reorganizing the on-chip reagents, reaction wells and work flow steps.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.